Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2014
09/02/2014US8822451 Modulators of ATP-binding cassette transporters
09/02/2014US8822446 Pyrrolopyridine inhibitors of kinases
09/02/2014US8822414 Heterocyclic compounds suitable for the treatment of dyslipidemia
08/2014
08/28/2014WO2014128719A2 Processes for the preparation of bispyribac sodium and intermediates thereof
08/28/2014WO2014128189A1 2-aminopyrimidine derivatives for the treatment of viral infections
08/28/2014WO2014093230A3 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
08/28/2014US20140243528 Rosuvastatin Enantiomer Compounds
08/28/2014US20140243362 Sulfonamide compounds and their use in the modulation retinoid-related orphan receptor
08/28/2014US20140243335 Substituted hydoxamic acids and uses thereof
08/27/2014EP2768813A1 Quinazoline derivatives as pi3k modulators
08/27/2014EP2768812A1 Acid addition salts of bosentan
08/27/2014EP2768811A1 Process for the preparation of an endothelin receptor antagonist
08/27/2014EP2768799A1 Substituted biaryl alkyl amides
08/26/2014US8816076 Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
08/26/2014US8816075 Process for the preparation of dihydroquinazolines
08/26/2014US8816074 2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections
08/26/2014US8815884 Prolyl hydroxylase inhibitors
08/26/2014US8815883 Compounds and methods for inhibiting serotonin synthesis
08/26/2014US8815881 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
08/26/2014US8815879 Substituted 4-(selenophen-2(or-3)-ylamino)pyrimidine compounds and methods of use thereof
08/26/2014US8815878 Spiro hemiaminals for treating viral diseases
08/26/2014US8815872 Macrocyclics pyrimidines as aurora kinase inhibitors
08/26/2014US8815865 Substituted 4-hydroxypyrimidine-5-carboxamides
08/26/2014US8815862 Co-crystal intermediates of rosuvastatin and methods of using same
08/26/2014US8815853 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
08/26/2014US8815852 Carbamoyloxy arylalkan arylpiperazine analgesics
08/26/2014US8815848 Compositions and methods for inhibition of the JAK pathway
08/26/2014US8815418 Compound including fluorenyl group for organic photoelectric device and organic photoelectric device including the same
08/26/2014CA2656618C Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
08/26/2014CA2653039C Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
08/21/2014WO2014124915A1 Preparation of alkaline earth metal-complexed metal bisamides from metal monoamides
08/21/2014US20140235858 Neuroprotective multifunctional antioxidants and their monofunctional analogs
08/21/2014US20140235638 Anti-Infective Agents and Uses Thereof
08/21/2014US20140235634 Therapeutic compounds and uses thereof
08/21/2014US20140235633 4-Aminoquinazoline Derivatives and Uses Thereof
08/21/2014US20140235583 Substituted pyrimidines
08/21/2014US20140234939 Benzamide Compounds and Related Methods of Use
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/21/2014US20140234245 N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
08/20/2014EP2767531A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
08/20/2014EP2766342A1 Phenyl-guanidine derivatives
08/19/2014US8809528 Quinazolinone derivatives useful as vanilloid antagonists
08/19/2014US8809427 Phthalocyanine compound and production method therefor, and coloring composition containing the phthalocyanine compound
08/19/2014US8809356 Inhibitors of NEDD8-activating enzyme
08/19/2014US8809354 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
08/19/2014US8809353 Quinazolines useful as modulators of voltage gated ion channels
08/19/2014US8809343 Pyrimidine derivative, preparation method and use thereof
08/19/2014US8809341 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
08/19/2014US8809339 Compounds and methods for inhibiting phosphate transport
08/19/2014US8809326 Isoquinolinone Rho kinase inhibitors
08/14/2014WO2014122267A1 Substituted benzamides with activity towards ep4 receptors
08/14/2014WO2014122160A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
08/14/2014US20140228388 Phenyl-Guanidine Derivatives
08/14/2014US20140228387 Disubstituted 5-fluoro-pyrimidines
08/14/2014US20140228385 Process for rilpivirine
08/14/2014US20140228362 Method of Treatment or Prophylaxis
08/14/2014US20140227221 Methods of treating multiple myeloma and resistant cancers
08/13/2014EP2765128A1 Substituted benzamides with activity towards EP4 receptors
08/13/2014EP2764866A1 Inhibitors of nedd8-activating enzyme
08/13/2014EP2763969A1 Ethynyl derivatives as metabotropic glutamate receptor modulators
08/13/2014CN103987699A 作为pi3k调节剂的喹唑啉衍生物 As quinazoline derivatives pi3k moderator
08/13/2014CN103987698A 作为激酶lrrk2调节剂用于治疗帕金森病的2-苯基氨基嘧啶衍生物 Amino-pyrimidine derivatives as kinase lrrk2 modifier used to treat Parkinson's disease 2-phenyl
08/13/2014CN103980209A 一种4-n-取代-5-氯喹唑啉类化合物及制备方法及应用 One kind of 5-chloro-4-n- substituted quinazoline compounds and preparation method and application
08/13/2014CN103980208A 厄洛替尼及其衍生物的制备方法 Erlotinib preparation Nepal and its derivatives
08/13/2014CN103980207A 一种盐酸厄洛替尼b型晶的合成方法 A synthesis method of erlotinib hydrochloride crystal type b
08/13/2014CN103980206A 一种嘧啶乙胺类化合物及其制备方法 A pyrimidine amine compounds and its preparation method
08/13/2014CN102382062B 一种环烷基芳基嘧啶类衍生物及其制备方法和用途 A cyclic alkyl aryl pyrimidine derivatives and their preparation and use
08/13/2014CN101304977B 具有全氟烷基的核酸碱类和其制备方法 Nucleic bases having a perfluoroalkyl group and a method for its preparation
08/12/2014US8802831 Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt
08/12/2014US8802697 Inhibitors of the fibroblast growth factor receptor
08/12/2014US8802686 Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine
08/12/2014US8802683 Compounds for use in treatment of mucositis
08/12/2014US8802675 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/12/2014US8802669 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
08/12/2014US8802666 Inhibitors of cyclophilins and uses thereof
08/12/2014US8802659 Bicyclic aryl sphingosine 1-phosphate analogs
08/12/2014US8802657 Compounds useful as Raf kinase inhibitors
08/12/2014US8802597 Herbicidal pyrimidines
08/12/2014US8801804 Non-metal tanning process
08/12/2014CA2726040C Quinazoline derivatives
08/12/2014CA2683941C Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
08/12/2014CA2527168C Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
08/07/2014WO2014118737A1 Erlotinib salts
08/07/2014WO2014117948A1 Novel substituted condensed pyrimidine compounds
08/07/2014WO2014117947A1 4-amino substituted condensed pyrimidine compounds as pde4 inhibitors
08/07/2014WO2014091167A3 Cyclopropylboronic compounds, method for preparing same and use thereof
08/07/2014US20140221411 2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient
08/07/2014US20140221405 Platelet adp receptor inhibitors
08/07/2014US20140221403 Quinazoline based egfr inhibitors containing a zinc binding moiety
08/07/2014US20140221401 Methods and compositions for treating pain
08/07/2014US20140221396 Tubulin inhibitors
08/07/2014US20140221371 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors
08/07/2014US20140221336 Compounds useful as inhibitors of janus kinases
08/07/2014US20140221335 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
08/07/2014US20140219989 Factor ixa inhibitors
08/06/2014EP2760844A1 Fluorogenic peptidase substrate
08/06/2014EP2760843A2 Selective nr2b antagonists
08/06/2014EP2760443A1 Sulfonamide compounds and their use in the modulation retinoid - related orphan receptor
08/06/2014CN103965276A 从野马追中快速分离纯化单体化合物的方法 The method is rapid separation and purification of the monomer compounds from the Mustang chase
08/06/2014CN103965198A 替卡格雷的中间体及其制备方法以及利用该中间体制备替卡格雷的方法 Ticagrelor intermediates and preparation methods and the use of a method for preparing the intermediate ticagrelor
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 427